Association between trans-palmitoleic acid and metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma: NHANES 1999–2018 by Qirui Li, Luqi Zhan, Qian Li, Shuai Zhu, Shuaihui Liu, He Jiang, Jinlin Cheng, Lanjuan Li

Subjects: “…MASLD…”
Get full text

Refining the Role of EGR1 as a Biomarker in MASLD [Letter] by Zeng X

Subjects: Get full text

A complement to epigenetics in metabolic dysfunction-associated steatotic liver disease: Editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in a... by Johanna K. DiStefano, Glenn S. Gerhard

Subjects: “…masld…”
Get full text

Association between arterial stiffness and MASLD in US young adults: base on NHANES 2005-2018 by Qing-zhong Li, Jia-xin Tan, Quan-Zhi Qin, Guo-tian Ruan, Teng Deng, Yi-zhen Gong

Subjects: Get full text

Exploratory Role of Flavonoids on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a South Italian Cohort by Caterina Bonfiglio, Rossella Tatoli, Rossella Donghia, Davide Guido, Gianluigi Giannelli

Subjects: “…MASLD…”
Get full text

Ferroptosis as a potential connection between schizophrenia and metabolic dysfunction-associated steatotic liver disease – a narrative review by Jakub Rogalski, Tomasz Tomczak

Subjects: Get full text

Interaction Between Periodontitis and MASLD: Pathophysiological Associations and Possibilities of Prevention and Therapy by Martina Juzbašić, Matej Tomas, Ana Petrović, Marija Hefer, Renata Sikora, Ana Mačković, Stjepan Siber, Martina Smolić

Subjects: “…MASLD…”
Get full text

Polychlorinated Biphenyl Exposure Alters tRNA Transcriptome in High-Fat Diet-Fed Mouse Liver by Carolyn M. Klinge, Julia H. Chariker, Kellianne M. Piell, Belinda J. Petri, Eric C. Rouchka, Matthew C. Cave

Subjects: “…MASLD…”
Get full text

Microbiota and metabolic dysfunction associated with steatotic liver disease by Q. Zhu, S. Francque, W. Kwanten

Subjects: Get full text

Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among a... by Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed

Subjects: “…masld…”
Get full text

Correspondence to editorial on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis” by Nicholas A. Rouillard, Linda Henry, Mindie H. Nguyen

Subjects: “…masld…”
Get full text

Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome Analysis by Gina Ryu, Eileen Laurel Yoon, Wankyu Kim, Dae Won Jun

Subjects: “…MASLD…”
Get full text

Genetic analysis of the correlation between GLP1 action and metabolic liver disease: Insights from Mendelian randomization analysis by Zhiqiang Ma, Binyu Wang, Danpei Li, Xi Chen

Subjects: Get full text

A murine model of gestational diabetes reveals MASLD risk and alterations in markers of hepatic mitochondrial metabolism by Grace E. Shryack, Grace E. Shryack, Grace E. Shryack, Alexa A. Krause, Alexa A. Krause, Alexa A. Krause, Simone Hernandez Ruano, Laura C. Schulz, Kathleen A. Pennington, R. Scott Rector, R. Scott Rector, R. Scott Rector

Subjects: Get full text

Fructose induces metabolic reprogramming in liver cancer cells, promoting aggressiveness and chemotherapy resistance by Lisette Chávez-Rodríguez, Alejandro Escobedo-Calvario, Verena Jendrossek, Johann Matschke, Maike Busch, Nicole Dünker, Moisés Vergara-Mendoza, Verónica Souza-Arroyo, Leticia Bucio-Ortiz, Roxana U. Miranda-Labra, Araceli Páez-Arenas, María Concepción Gutiérrez-Ruiz, Diego F. Calvisi, Luis E. Gomez-Quiroz

Subjects: Get full text

Hepatokine leukocyte cell‐derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction‐associated steatotic liver disease in the general popu... by Keita Suzuki, Hiromasa Tsujiguchi, Akinori Hara, Yumie Takeshita, Hisanori Goto, Yujiro Nakano, Reina Yamamoto, Hiroaki Takayama, Atsushi Tajima, Tatsuya Yamashita, Masao Honda, Hiroyuki Nakamura, Toshinari Takamura

Subjects: Get full text

Readily Available Index of Insulin Sensitivity Is Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes by Stefano Ciardullo, Alessandro Roberto Dodesini, Emanuele Muraca, Pietro Invernizzi, Roberto Trevisan, Gianluca Perseghin

Subjects: Get full text

MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic... by Ying Wang, Shengfeng Wang, Xiude Fan, Jiajun Zhao, Yongfeng Song

Subjects: Get full text

Relationship between anthropometric measures and the risk of incident Metabolic dysfunction-associated steatotic liver disease: a longitudinal study by Takahiro Ichikawa, Yoshitaka Hashimoto, Takuro Okamura, Akihiro Obora, Takao Kojima, Hiroshi Okada, Masahide Hamaguchi, Michiaki Fukui

Subjects: Get full text

Post‐hoc analysis of the tofogliflozin post‐marketing surveillance study (J‐STEP/LT): Tofogliflozin improves liver function in type 2 diabetes patients regardless of BMI by Hiroyuki Uchinuma, Mitsunori Matsushita, Masaya Tanahashi, Hideki Suganami, Kazunori Utsunomiya, Kohei Kaku, Kyoichiro Tsuchiya

Subjects: Get full text